Ligand Pharmaceuticals, Inc. (LGND) Tops Q1 EPS by 10c
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $284.70 +3.45%
EPS Growth %: -24.9%
Financial Fact:
Research and development: 5.9M
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: -24.9%
Financial Fact:
Research and development: 5.9M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) reported Q1 EPS of $0.35, $0.10 better than the analyst estimate of $0.25. Revenue for the quarter came in at $16 million versus the consensus estimate of $13.63 million.
For earnings history and earnings-related data on Ligand Pharmaceuticals, Inc. (LGND) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- UBS Upgrades Kyocera (6971:JP) (KYOCY) to Buy
- AM Best Revises Outlooks to Positive for Triangle Insurance Company
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
